- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (22)
7 result(s) found for: Sterol.
Displaying page 1 of 1.
EudraCT Number: 2016-003281-84 | Sponsor Protocol Number: EXCRETE | Start Date*: 2018-03-27 |
Sponsor Name:Academical Medical Centre, department of internal | ||
Full Title: The Effect of UrsodeoXyCholicacid (UDCA) and ezetimibe on total faecal steRol ExcreTion and plasma lipid lEvels | ||
Medical condition: Familial hypercholesterolemia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-002079-24 | Sponsor Protocol Number: NL61855.018.17 | Start Date*: 2018-01-22 | |||||||||||
Sponsor Name:Academic Medical Center | |||||||||||||
Full Title: Targeting the secondary bile acid glycodeoxycholic acid as therapeutic strategy in type 2 diabetes mellitus. | |||||||||||||
Medical condition: Type 2 diabetes mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004413-33 | Sponsor Protocol Number: KBT-004 | Start Date*: 2007-10-26 | |||||||||||
Sponsor Name:Karo Bio AB | |||||||||||||
Full Title: A Phase II, Placebo-Controlled, Double-Blind, Randomised, 12-Week, Parallel-group Study to Assess the Efficacy of Different Doses of KB 2115 as add on to Statin Treatment in Patients With Dyslipid... | |||||||||||||
Medical condition: Primary hypercholesterolaemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) FI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-001528-37 | Sponsor Protocol Number: Cholzuur | Start Date*: 2020-04-09 |
Sponsor Name:Cbusinez | ||
Full Title: Long-term safety study of personalized magistral prepared cholic acid capsules in patients with bile acid synthesis defects | ||
Medical condition: Patients with phenotypically mild Zellweger Spectrum Disorder (ZSD) or a Single Enzyme Defect (SED) in bile acid synthesis. | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-003191-35 | Sponsor Protocol Number: KBT-003 | Start Date*: 2006-10-09 | |||||||||||
Sponsor Name:Karo Bio AB | |||||||||||||
Full Title: A placebo controlled, double blind, randomised, 12-week, phase II study to assess the safety and efficacy of KB2115 in patients with primary hypercholesterolemia | |||||||||||||
Medical condition: Primary Hypercholesterolemia. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-001518-39 | Sponsor Protocol Number: K-877-303 | Start Date*: 2017-01-16 | |||||||||||
Sponsor Name:Kowa Research Institute, Inc. | |||||||||||||
Full Title: A Phase 3, Multi-Center, Placebo-Controlled, Randomized, Double-Blind, 12-Week Study With a 40-Week, Active-Controlled, Open-Label Extension to Evaluate the Efficacy and Safety of K-877 in Adult Pa... | |||||||||||||
Medical condition: Severe hypertriglyceridemia [fasting TG levels >=500 mg/dL (5.65 mmol/L) and <2000 mg/dL (22.60 mmol/L) and mild or moderate renal impairment. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) PL (Completed) BG (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003511-37 | Sponsor Protocol Number: K-877-301 | Start Date*: 2017-01-16 | |||||||||||
Sponsor Name:Kowa Research Institute, Inc. | |||||||||||||
Full Title: A Phase 3, Multi-Center, Placebo-Controlled, Randomized, DoubleĀBlind, 12-Week Study With a 40-Week, Active-Controlled, DoubleĀBlind Extension to Evaluate the Efficacy and Safety of K-877 in Adult ... | |||||||||||||
Medical condition: severe hypertriglyceridemia [fasting TG levels >=500 mg/dL (5.65 mmol/L) and <2000 mg/dL (22.60 mmol/L) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) CZ (Completed) BG (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.